sayali wadke’s Post

At Teva, we know that providing medicines is an important job—and conducting business ethically and responsibly is non-negotiable. In 2021, we trained 20,000+ employees on ethics (99.6% of those assigned), published three new position statements on patient safety, responsible supply chain and risk management, and ranked in the top 1% in our industry in the @EcoVadis sustainable procurement assessment—as we consider our supply chain partners to be an extension of our company. Find our latest #governance highlights in our 2021 ESG Progress Report: #ESG #sustainability #environment #ethics #socialimpact #Tevapharm #TevaESG

The most important Pharma supply chain issues revealed in PSCI - Pharmaceutical Supply Chain Initiative’s 2024 Materiality Assessment. The issues ranked highest for both financial impact & planetary impact include: - Anti-bribery and corruption – processes to prohibit corruption in the value chain - Pharmaceuticals in the Environment (PiE) and Anti-Microbial Resistance (AMR) – controlling the release of active ingredients, including those with the potential to lead to AMR. - Decarbonisation – reducing carbon emissions from the value chain. - Climate resilience – the resilience of supply chains to the weather and other changes that will result from a changing climate - Biosafety – containment of biological substances in a labour manufacturing context PSCI are the official sustainability partner to #CDMOLive Don't miss the interactive roundtable hosted by Robert Williams, PSCI Vice Chair & Director of Sustainable Procurement at AstraZeneca: Strategies for reducing scope 3 emissions with manufacturing partners Responsible lobbying – ensuring political engagement is transparent and aligned with the public interest. https://lnkd.in/dQifQ7nb

As a pharmaceutical manufacturer, safeguarding the environment and ensuring the well-being of your customers and employees are fundamental responsibilities. The pharmaceutical industry operates in a highly regulated environment, where environmental stewardship and social accountability are critical to long-term success. Conducting environmental risk assessments and ensuring strict compliance with regulations are not just about meeting legal requirements. They also: ✅Reduce Operational Costs: Identifying and mitigating environmental risks early can lower waste management expenses and energy consumption. ✅Avoid Penalties and Legal Issues: Proactive compliance prevents costly fines and interruptions to operations. ✅Enhance Brand Reputation: Demonstrating environmental responsibility builds trust among consumers, investors, and stakeholders, strengthening your position in the market. ✅Promote Employee Well-Being: A safe, eco-conscious workplace fosters a healthier environment for employees and boosts morale. ✅Support Sustainability Goals: Implementing green practices contributes to global sustainability efforts, aligning your operations with broader environmental objectives. By integrating environmental risk management into your operations, you not only protect your business from potential risks but also contribute positively to the health of the planet and the communities you serve. Remember, sustainable practices are not just good ethics—they are good business. #EnvironmentalCompliance #Sustainability #PharmaceuticalIndustry

Interesting article as always from PharmaSource regarding 2024's most pressing supply chain issues in the pharma industry. Certainly keen to hear the thoughts and comments from my supply chain network!

[Promoting Ethical Alternatives & Product Safety: Washington State Bans Animal-Tested Cosmetics] On the 25th of March 2024, Washington State enacted HB 1097, banning the sale of newly animal-tested cosmetics effective the 1st of January 2025. Eurofins Cosmetics & Personal Care's team of experts is prepared to help you select the optimal tests for your cosmetic projects. We emphasise quick compliance with regulatory standards, ensuring a smooth development process for your initiatives. Read more ➡ https://lnkd.in/gWqz66JT #eurofins #regulatory #invitro #Ethical #GlobalExpertisePersonalTouch

A responsible company must be able to rely on the fact that its entire supply chain respects the environment, human rights and labour laws. 🌎 Read our article to find out 💡 what is the biggest environmental challenge facing the pharmaceutical industry? 💡 how do we select and monitor our partners' activities throughout the supply chain? 💡 how have we succeeded in improving our energy efficiency and reducing our carbon dioxide emissions? #EnvironmentalResponsibility #ResponsiblyForward #Orion

Champions uphold the highest ethics, making them true pathfinders in their actions.✨ May is the month of the ESG Marathon, featuring diverse ESG topics for various industry sectors. 🌍 Recently, we completed a session on External Providers Evaluation, led by an ESG trainer for process owners in a pharmaceutical firm. 💊 The ESG evaluation of suppliers begins with the supplier onboarding SOP and is linked to their ESG Materiality Assessment. 📋🔗 For ESG External Provider Assessment Sheet ping ⭐ #ESG #ESGSupplier #BRSR #ESGEvaluation #Sathyanarayananchampion #IINVTY #ISDE

What does a healthy future look like to you? Maybe a world with thriving people, a clean environment, honesty and respect? At Teva, we want that, too. Our 2023 Healthy Future Report (which went live today!) shows how we’re making this a reality through our focus on sustainability. Here are a few highlights: 👥 7 access to medicines programs to date, delivering important treatments to patients who wouldn’t otherwise have them (ahead of schedule to reach our goal of 8 by 2025) 🌍 27% reduction in greenhouse gas emissions from our operations and purchased energy compared to 2019 (achieving our 2025 target two years ahead of schedule) and set a bold new target to achieve #NetZero emissions by 2045 💼 Nearly 100% of targeted active employees trained on compliance and ethics, reinforcing culture of integrity Learn more about how we are working to create the future we want to see: https://lnkd.in/ejShWVqg #Tevapharm #Sustainability #HealthyFuture For the Environmental sustainability part nothing would have been possible without our Energy Champions, our EHS&S community in particular #Josh Decktor - Mor Maoz - Michael G. Mahoney - Ayala Oren - and the Regional EHS&S leaders and supports#

📢 𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝗮𝗹 𝗥𝗶𝘀𝗸 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 : 𝗧𝗵𝗲 𝗻𝗲𝘄 𝗘𝗠𝗔 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱! ➡ https://lnkd.in/eXHvSDcF 💊 The Environmental Risk Assessment (ERA) is a mandatory requirement when submitting a Marketing Authorisation Application (MAA). ✅ The new Guideline on the environmental risk assessment of medicinal products for human use recommends a double assessment to evaluate the potential impacts of active substances on the environment: 🔸 Risk Assessment 🔸 Hazard Assessment The new Guideline will be effective from September 2024. ➡ For more details on new recommendations, at CEHTRA, we answer your questions and provide guidance on new practices to follow. #pharma #EMA #guideline #environment #riskassessment

📢 European Biocides Regulation: overcoming challenges for a stronger and more competitive industry The EU Biocidal Products Regulation (BPR) is central to maintaining a safe and equitable market in the European biocide sector. Nevertheless, several challenges continue to affect business operations and regulatory efficiency. 🌐 🚩 Key Challenges: 1. Delays in the Review Program (RP) for active substances (AS) The review program for active substances faces delays, creating uncertainty for producers, with some substances under evaluation for over 15 years. These extended delays slow the market entry of new products and result in uneven treatment of applicants. 2. Data protection and risk of free-riding Under Article 95(5) of the BPR, protections for data investments by companies will soon expire for certain substances, exposing them to possible use by competitors without fair compensation. This situation could undermine investment in crucial safety and compliance data, putting the industry's most innovative firms at risk. 3. Market Imbalance Different approaches to BPR implementation across member states have led to variations in interpretation and compliance timelines. Companies, particularly SMEs, face heavy burdens, with high compliance costs adding to a competitive imbalance. 💡 Steps toward a more robust regulatory framework: 1. Aligning BPR Enforcement Across Member States Standardizing application of the BPR throughout the EU could help eliminate discrepancies in treatment and reduce unfair disadvantages for businesses. Increased coordination among authorities would further support uniform enforcement. 2. Prolonging data protection Extending data protection for biocidal substances, as originally intended, would help the regulatory framework reflect current industry conditions, promote R&D investment, and deter free-riding. 3. Optimizing the Review Program Simplifying administrative and technical requirements within the review program could speed up active substance approvals, allowing better planning for manufacturers and preventing excessive delays. To address these challenges, the biocide industry advocates for regulatory updates that foster a fairer and more innovation-friendly market. Enhanced collaboration among regulators, businesses, and stakeholders will be vital and critical to strengthen industry competitiveness across the European market. 🌍💼 #BiocidesRegulation #BPR #ChemicalIndustry #Innovation #FairCompetition #EU #AIRCompEX #DataProtection